A detailed history of Aton Ra Partners transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 2,122 shares of A stock, worth $285,387. This represents 0.59% of its overall portfolio holdings.

Number of Shares
2,122
Previous 2,328 8.85%
Holding current value
$285,387
Previous $260,000 13.46%
% of portfolio
0.59%
Previous 0.55%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$101.17 - $139.82 $20,841 - $28,802
-206 Reduced 8.85%
2,122 $295,000
Q3 2023

Oct 25, 2023

SELL
$109.73 - $128.47 $5,596 - $6,551
-51 Reduced 2.14%
2,328 $260,000
Q2 2023

Jul 18, 2023

SELL
$114.69 - $141.28 $58,491 - $72,052
-510 Reduced 17.65%
2,379 $286,000
Q1 2023

May 05, 2023

SELL
$131.13 - $159.06 $53,238 - $64,578
-406 Reduced 12.32%
2,889 $399,000
Q4 2022

Feb 02, 2023

SELL
$125.64 - $157.68 $82,671 - $103,753
-658 Reduced 16.65%
3,295 $493,000
Q3 2022

Nov 14, 2022

SELL
$115.11 - $142.29 $119,944 - $148,266
-1,042 Reduced 20.86%
3,953 $480,000
Q2 2022

Aug 15, 2022

SELL
$112.71 - $135.93 $929,632 - $1.12 Million
-8,248 Reduced 62.28%
4,995 $593,000
Q1 2022

May 16, 2022

SELL
$126.0 - $156.48 $770,364 - $956,718
-6,114 Reduced 31.59%
13,243 $1.75 Million
Q4 2021

Feb 14, 2022

SELL
$147.95 - $164.3 $198,400 - $220,326
-1,341 Reduced 6.48%
19,357 $3.09 Million
Q3 2021

Nov 15, 2021

BUY
$147.58 - $179.28 $270,661 - $328,799
1,834 Added 9.72%
20,698 $3.26 Million
Q2 2021

Aug 12, 2021

SELL
$127.69 - $148.81 $49,671 - $57,887
-389 Reduced 2.02%
18,864 $2.79 Million
Q1 2021

May 17, 2021

SELL
$114.99 - $130.12 $111,885 - $126,606
-973 Reduced 4.81%
19,253 $2.45 Million
Q4 2020

Feb 19, 2021

BUY
$100.01 - $119.3 $2.02 Million - $2.41 Million
20,226 New
20,226 $2.4 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.8B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.